Cargando…
The combined effects of microglia activation and brain glucose hypometabolism in early-onset Alzheimer’s disease
BACKGROUND: Early-onset Alzheimer’s disease (EOAD) is characterized by young age of onset (< 65 years), severe neurodegeneration, and rapid disease progression, thus differing significantly from typical late-onset Alzheimer’s disease. Growing evidence suggests a primary role of neuroinflammation...
Autores principales: | Tondo, Giacomo, Iaccarino, Leonardo, Caminiti, Silvia Paola, Presotto, Luca, Santangelo, Roberto, Iannaccone, Sandro, Magnani, Giuseppe, Perani, Daniela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193377/ https://www.ncbi.nlm.nih.gov/pubmed/32354345 http://dx.doi.org/10.1186/s13195-020-00619-0 |
Ejemplares similares
-
Brain glucose metabolism in Lewy body dementia: implications for diagnostic criteria
por: Caminiti, Silvia Paola, et al.
Publicado: (2019) -
FDG-PET and CSF biomarker accuracy in prediction of conversion to different dementias in a large multicentre MCI cohort
por: Caminiti, Silvia Paola, et al.
Publicado: (2018) -
(11)C‐PK11195 PET–based molecular study of microglia activation in SOD1 amyotrophic lateral sclerosis
por: Tondo, Giacomo, et al.
Publicado: (2020) -
A biomarker study in long-lasting amnestic mild cognitive impairment
por: Cerami, Chiara, et al.
Publicado: (2018) -
An in vivo (11)C‐PK PET study of microglia activation in Fatal Familial Insomnia
por: Iaccarino, Leonardo, et al.
Publicado: (2017)